Navigation Links
Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
Date:8/19/2007

third Phase 2a study to evaluate the ability of MEDI-528 to inhibit the biological activity of IL-9 in the bronchoalveolar lavage fluid of adult patients with atopic asthma are underway.

About IL-9

As mentioned above, IL-9 has been associated with symptoms of asthma. It is one of at least 29 naturally occurring interleukins in the human body. Overexpression of IL-9 in animal models has been shown to result in many features of asthma, including increased airway inflammation and hyperreactivity. Blocking the actions of IL-9 has been shown to reduce the airway inflammation and increased airway inflammation and increased airway hyperresponsiveness seen in animal models of asthma. MedImmune is conducting research to evaluate the potential to use MAbs targeting IL-9 to treat or prevent symptomatic, moderate-to-severe, persistent asthma.

About Asthma

Asthma is a chronic disease of the airways that may cause wheezing, breathlessness, chest tightness and coughing. According to the U.S. Centers for Disease Control and Prevention (CDC), more than 30 million Americans reported having a history of asthma in 2003. About 20 million said they currently had asthma. In 2000, the CDC reported that there were more than 10 million asthma-related outpatient visits to private physician offices and hospital clinics. The National Institutes of Health (NIH) have estimated asthma-related healthcare costs in the U.S. at $14 billion annually.

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a Phase 1 trial in obesity. In addition, Genaera has a value-driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing Phase 2 clinical testing i
'/>"/>

SOURCE Genaera Corporation

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, Systemic Lupus ... Market Forecasts to 2015 ,, ... Lupus Erythematosus - Drug Pipeline Analysis ... Summary ,, GlobalData, the ...
(Date:12/15/2009)... HA,AYIN, Israel, December 15 EnzySurge ... the advanced chronic,wound management market, announced today ... Food and Drug Administration (FDA) to market ... FDA also cleared,DermaSept, an Over-the-Counter version of ... EnzySurge is the developer of the ...
(Date:12/15/2009)... Dec. 15 NxStage Medical, Inc. (Nasdaq: ... dialysis products, today announced that a group of ... be embarking on a week-long, conventional (non-dialysis) Caribbean ... The cruise, dubbed the "2010 Freedom Cruise: We,re ... Fla. on January 3, 2010 and returns on ...
Breaking Medicine Technology:Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8EnzySurge Receives FDA Approval for SilverStream(TM) Innovative Wound Management Solution 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Study shows family caregivers simple touch techniques reduce symptoms in cancer patients 61568 1Study shows family caregivers simple touch techniques reduce symptoms in cancer patients 61568 2Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 1Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 2Oscar Pistorius artificial limbs give him clear major advantage for sprint running 10776 3Benefits of Eating Fish May Depend on Preparation 61563 1Benefits of Eating Fish May Depend on Preparation 61563 2
(Date:12/15/2009)... dementia risk, research finds , , TUESDAY, Dec. 15 (HealthDay ... that regulates appetite, may guard against Alzheimer,s disease, new ... this may be one of many agents that we ... senior study author Dr. Sudha Seshadri, an associate professor ... it may be one of many markers that we ...
(Date:12/15/2009)... education program will train advocates to be leaders ... Project developed with support from experts in online ... ,, WASHINGTON, Dec. 15 ... are accepting applications for the first-ever "Malaria Griots" ... and educate participants to become leaders in the ...
(Date:12/15/2009)... NEW YORK, Dec. 15 The following are ... Attorney General for the criminal division, at the ... you, Secretary Sebelius. And thank you for the ... the HEAT initiative. ,, Together, our Departments ... lasting results. ,, We,ve made tremendous progress in ...
(Date:12/15/2009)... Mich. A new study links chronic obstructive pulmonary ... act as sentinels to activate the body,s immune system. ... research adds to growing awareness of the immune system,s ... affects more than 12 million Americans with wheezing, shortness ... factors is key if doctors are to find better ...
(Date:12/15/2009)... that phthalates actually cause the condition, experts ... Common chemicals found in plastic toys and elsewhere ... in boys, preliminary research suggests. , The ... pediatricians, adds fuel to the debate over these ... by some scientists. The chemical industry claims the ...
Breaking Medicine News(10 mins):Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3
... 13, 2008 Five neonatology fellows have been ... in the area of follow-up care of the ... The grants, which underscore MedImmune,s commitment to expanding ... institution a $35,000 grant, totaling $175,000 in research ...
... Fall Should Not Pose Setback and Expects the 89-Year-Old ... Evangelist to Recover ... to his mountain home in Montreat, N.C. upon his release this,afternoon ... admitted for observation after he tripped over one of his three ...
... form of disease by 20 years after operation, study ... transplant patients have a higher incidence of cancer than ... In a new study published in the October issue ... risk pattern in 540 Finnish liver transplant recipients from ...
... Oct. 10 Do you think that the blind,can,t ... the October,17 open house at the Virginia Rehabilitation Center ... there empower the blind and,visually impaired to lead productive, ... The center, located at 401 Azalea Avenue, is holding ...
... Life Sciences Inc.,(NuView) has agreed to assume management ... the linear accelerator and cyclotron,production facilities in Denton, ... Iodine-123 and Thallium-201 used in,molecular imaging and nuclear ... "We are confident that by improving operational,efficiencies at ...
... blame , , FRIDAY, Oct. 10 (HealthDay News) -- In a ... associated with a higher death rate, according to a new ... the Journal of General Internal Medicine , researchers from ... of 75.6 years) who had diabetes and were enrolled in ...
Other Medicine News:Health News:MedImmune grants 5 new fellowships to help expand premature infant follow-up care research 2Health News:Billy Graham Returns Home Following Hospital Observation 2Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Older Diabetics With Depression Face Higher Death Rate 2
Chemically Resistant Sealing Mat for 384ch, Square Well Available Sterile...
Silicone Compression Mat, Bulk...
... Alpha unit, these new pads may be used in ... runs may be sealed with the same pad. ... a microplate from sticking to the block and lid, ... sealing performance, which means you can use as little ...
Easy to pierce, remove using foil stripper...
Medicine Products: